Pages that link to "Q40312042"

The following pages link to Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma (Q40312042):

Displaying 24 items.

• Merkel Cell Carcinoma: Epidemiology, Target, and Therapy (Q26824521) (← links)
• Mutational analysis of merkel cell carcinoma (Q27021034) (← links)
• Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy (Q31111719) (← links)
• Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc (Q33696336) (← links)
• Activation of the PI3K/AKT pathway in Merkel cell carcinoma (Q34170708) (← links)
• A Proteomic Study of Human Merkel Cell Carcinoma (Q34274250) (← links)
• Merkel cell carcinoma: critical review with guidelines for multidisciplinary management (Q34631014) (← links)
• RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy (Q34634649) (← links)
• BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo (Q35066871) (← links)
• Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma (Q37420605) (← links)
• Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma (Q38714104) (← links)
• KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro (Q39653324) (← links)
• Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. (Q40005196) (← links)
• RKIP does not contribute to MAP kinase pathway silencing in the Merkel Cell Carcinoma cell line UISO. (Q40063028) (← links)
• Molecular mechanisms supporting a pathogenic role for human polyomavirus 6 small T antigen: Protein phosphatase 2A targeting and MAPK cascade activation (Q40579796) (← links)
• Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis (Q46847155) (← links)
• Small T-antigen of the TS-associated polyomavirus activates factors implicated in the MAPK pathway (Q51047175) (← links)
• Merkel cell carcinoma--pathogenesis, clinical aspects and treatment. (Q53219035) (← links)
• Merkel cell carcinoma (Q56681295) (← links)
• The biology and treatment of Merkel cell carcinoma: current understanding and research priorities (Q57030149) (← links)
• Loss of RKIP expression is associated with poor survival in GISTs (Q63405991) (← links)
• Expression profiles associated with aggressive behavior in Merkel cell carcinoma (Q79370590) (← links)
• [Merkel cell carcinoma] (Q85335650) (← links)
• Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts (Q96127021) (← links)